Cleary Chris Insider Trades

Insider Trading History

Track insider trading activity for Cleary Chris. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Director
Holding Value $123k 33,391 shares
Last Trade
Jun 24, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14k 3,510 shares
$3.98
$3.69
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Director
Holding Value $157k 42,553 shares
Last Trade
Jun 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$172k 42,553 shares
$4.04
$3.69
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Director
Holding Value $136k 36,901 shares
Last Trade
Feb 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.51k 676 shares
$3.71
$3.69
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Director
Holding Value $139k 37,577 shares
Last Trade
Aug 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39k 15,000 shares
$2.60
$3.69
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Director
Holding Value $136k 36,797 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 36,797 shares
$3.22
$3.69
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Director
Holding Value $113k 30,742 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$172k 30,742 shares
$5.58
$3.69

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up